Dr. Reisler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7503 Surratts Road
Clinton, MD 20735Phone+1 301-868-8000
Education & Training
Emory University School of MedicineFellowship, Infectious Disease, 1996 - 1999
Rush University Medical CenterResidency, Internal Medicine, 1993 - 1996
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1993
Certifications & Licensure
MD State Medical License 2000 - 2025
GA State Medical License 1996 - 1999
IL State Medical License 1993 - 1996
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy Start of enrollment: 2005 Jan 01
- Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine Start of enrollment: 2008 Jun 03
- Western Equine Encephalitis Vaccine, Inactivated Start of enrollment: 2010 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsIntensive Care Unit-Like Care of Nonhuman Primates with Ebola Virus Disease.Paul W Blair, Mark G. Kortepeter, Lydia G Downey, Cristian Madar, Isaac L Downs
The Journal of Infectious Diseases. 2021-08-16 - 6 citationsSafety and immunogenicity of an inactivated eastern equine encephalitis virus vaccineBenjamin C. Pierson, Anthony P. Cardile, Arthur C. Okwesili, Isaac L. Downs, Ronald B. Reisler
Vaccine. 2021-05-12 - 1 citationsThe Western Equine Encephalitis Lyophilized, Inactivated Vaccine: An Update on Safety and Immunogenicity.Maryam Keshtkar-Jahromi, Ronald B. Reisler, Jeannine M. Haller, Denise P. Clizbe, Robert G. Rivard
Frontiers in Immunology. 2020-11-09
Press Mentions
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 TherapeuticsJune 29th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
